Released Feb 25, 2019, after the close
10-K filed Feb 25, 2019, 56 days after period end · 0001564590-19-004093
Q4 2018 · 10-K
Revenue$121.08M$121.08M +3.6% vs Q4 2017+8.4% vs Q3 2018
Net Income$8.87M$8.87M +465.8% vs Q4 2017N/M vs Q3 2018
EPS Diluted$0.46$0.46 +475.0% vs Q4 2017N/M vs Q3 2018
Gross Profit$95,452,000+2.3%
Operating Income$12,402,000−30.6%
Operating Cash Flowderived$21,089,000−29.3%
Free Cash Flowderived$17,083,000−35.8%
Margins · derived
Gross margin78.8%−1.0 pt vs Q4 2017
Operating margin10.2%−5.0 pt vs Q4 2017
Net margin7.3%+6.0 pt vs Q4 2017
What the release said
The release
Same quarter
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $121.08M | $116.90M | $108.54M | $104.62M |
| Net Income | $8.87M | $1.57M | -$3.24M | $3.37M |
| EPS Diluted | $0.46 | $0.08 | -$0.18 | $0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR